CN1147401A - Medicine for heart disease - Google Patents
Medicine for heart disease Download PDFInfo
- Publication number
- CN1147401A CN1147401A CN96115786A CN96115786A CN1147401A CN 1147401 A CN1147401 A CN 1147401A CN 96115786 A CN96115786 A CN 96115786A CN 96115786 A CN96115786 A CN 96115786A CN 1147401 A CN1147401 A CN 1147401A
- Authority
- CN
- China
- Prior art keywords
- radix
- medicine
- grams
- heart disease
- treatment
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Abstract
The medicine is prepared with 18 kinds of Chinese medicinal material including red sage root, selfheal spike, sophora flavescens, etc. It has good curative effect on coronary heart disease, angina pectoris, arrhythmia, tachycardia, myocardial infarction and other diseases. It has wide curing range, fast effect, long stable period, no medicine dependence and no toxic side-effect.
Description
Traditional Chinese medicine technology scope of the present invention relates to the cardiopathic medicine of a kind of treatment.
Chinese patent drugs for treatment heart disease, it is little generally to have a side effect, and price is more cheap, characteristics such as taking convenience.Coronary pill, pill for promoting coronary circulation, pills for curing heart disease, SHANHAI PILL etc. are closed by the Soviet Union that has commonly used in the cardiopathic Chinese patent medicine of existing treatment, all disease resultant effects such as angina pectoris, myocardial ischemia, premature beat, coronary heart disease, arrhythmia are poor, the course of treatment is long to improving for these medicines, low to heart disease cure rate and hypertension effective percentage, and price is higher.
The purpose of this invention is to provide a kind of medicine, to overcome above-mentioned deficiency of the prior art to the treatment heart disease that the treating cardiovascular disease resultant effect is good, evident in efficacy, price is lower.
Technical scheme of the present invention is, the medicament composing prescription proportioning is substantially, Radix Salviae Miltiorrhizae 10, two 2-4, Spica Prunellae 2-4, Radix Sophorae Flavescentis 5-8, Radix Codonopsis 4-7, LISHEN 2-4, Radix Ophiopogonis 1-3, Fructus Schisandrae Chinensis 1-2, Radix Astragali 2-5, Radix Angelicae Sinensis 1-2, Radix Paeoniae Rubra 2-4, Radix Glycyrrhizae Preparata 1-2, Radix Curcumae 1-3, Pericarpium Citri Reticulatae 1-3, Radix Notoginseng 1-2, Radix Puerariae 1-2, Rhizoma Cimicifugae 1-2, Colla Corii Asini 2-4 of colluding.
Its Cui proportioning is: Radix Salviae Miltiorrhizae 10, two 2.5-4, Spica Prunellae 2.5-4, Radix Sophorae Flavescentis 5.5-7, Radix Codonopsis 3.5-6, LISHEN 2.5-3.5, Radix Ophiopogonis 1.5-2.5, Fructus Schisandrae Chinensis 1.5, Radix Astragali 2.5-4, Radix Angelicae Sinensis 1.5, Radix Paeoniae Rubra 2.5-3.5, Radix Glycyrrhizae Preparata 1.5, Radix Curcumae 1.5-3, Pericarpium Citri Reticulatae 1.5-3, Radix Notoginseng 1.5, Radix Puerariae 1.5, Rhizoma Cimicifugae 1.5, Colla Corii Asini 2.5-3.5 of colluding.
For strengthening the effect of diseases such as medicine antianginal of the present invention, various arrhythmia, myocarditis, myocardial infarction and coronary heart disease, can in said prescription, add Rhizoma Chuanxiong, the ratio of Rhizoma Chuanxiong in medicine is 2.5-2.8.
The preparation process of medicine of the present invention is, each flavor Chinese medicine is got the raw materials ready by the prescription proportioning, and extracting liquorice is processed with the honey stir-fry; With Radix Glycyrrhizae and other flavor Chinese medicine pulverize separately, sieve, mixing; To expect powder and Mel mixing, rubbing is molded into ball.
Medicine of the present invention is to be guidance with the theories of Chinese materia medica, realize according to the pharmacology compatibility of Chinese crude drug, Radix Salviae Miltiorrhizae, twoly collude, Spica Prunellae three medicines share blood circulation promoting and blood stasis dispelling, removing heat from blood detumescence, nourishing YIN for tranquillization, blood pressure lowering; Radix Sophorae Flavescentis, Radix Codonopsis, LISHEN, Radix Ophiopogonis, Fructus Schisandrae Chinensis, the Radix Astragali share, myocardial ischemia, supraventricular premature beat, acute angina pectoris, coronary heart disease etc. are had significant therapeutic effect, to various cardiovascular disease, pulmonary heart disease, rheumatic heart disease, hypertensive cardiopathy, various chronic disease and improve cancer later stage chemotherapy, caused by radiation leukopenia, dizziness, feel sick, vomit, become thin, asthenia, weak therapeutical effect arranged also; Radix Salviae Miltiorrhizae, twoly collude, Spica Prunellae, Radix Sophorae Flavescentis, LISHEN, Radix Ophiopogonis, Fructus Schisandrae Chinensis, the Radix Astragali share, can improve the nucleic acid metabolism of myocardial cell, acid base imbalance there is not tangible influence, but can significantly improve arterial partial pressure of oxygen and blood oxygen saturation, all persons that is diagnosed as the tachy-arrhythmia, interaction property intensity is bordering on isoproterenol, really has good rising heart rate and improve sinuatrial node and chamber conduction, and sick sinus syndrome is had good result; Composition of medicine of the present invention, ventricular premature contraction, viral myocarditis, arrhythmia, arrhythmia atrial fibrillation room Piao, tachycardias intractable insomnia, sinuatrial node syndrome, coronary heart disease, angina pectoris, chronic heart failure fungal infection, hypertension, myocardial infarction all there is special curative effect, and can be anti-aging, coronary heart disease, flu, cancer, can hemopoietic function, to improving dizziness, fatigue and weakness that radiotherapy causes, becoming thin, feel sick, vomit and leukopenia that other reasons cause also has significant curative effect.It is low, applied widely that this medicine has a cost, and effect is fast, and curative effect is reliable, and stabilization time is long, no drug dependence, and advantage such as have no side effect.
This medicine can be made into pill, and adult's dose is generally every day three times, each nine grams.This medicine and the cardiopathic medicine of treatment commonly used such as storax pill for treating coronary heart disease, Ying Xindan, the clinical use Comparison of therapeutic of coronary disease health see Table 1, table 2.
Embodiment one: get Radix Salviae Miltiorrhizae 10 gram, two 2 grams, Spica Prunellae 2 grams, Radix Sophorae Flavescentis 5 grams, Radix Codonopsis 4 grams, LISHEN 2 grams, Radix Ophiopogonis 1 gram, Fructus Schisandrae Chinensis 1 gram, the Radix Astragali 2 grams, Radix Angelicae Sinensis 1 gram, Radix Paeoniae Rubra 2 grams, Radix Glycyrrhizae Preparata 1 gram, Radix Curcumae 1 gram, Pericarpium Citri Reticulatae 1 gram, Radix Notoginseng 1 gram, Radix Puerariae 1 gram, Rhizoma Cimicifugae 1 gram, Colla Corii Asini 2 grams of colluding, Radix Glycyrrhizae is processed back and other 17 flavor Chinese medicine pulverize separately with the honey stir-fry, sieve, mixing, get proper honey and mix rubbing, be molded into pill, every ball 9 grams get final product.
Embodiment two: get Radix Salviae Miltiorrhizae 10 gram, two 4 grams, Spica Prunellae 4 grams, Radix Sophorae Flavescentis 8 grams, Radix Codonopsis 7 grams, LISHEN 4 grams, Radix Ophiopogonis 3 gram, Fructus Schisandrae Chinensis 2 grams, the Radix Astragali 4 grams, Radix Angelicae Sinensis 4 grams, Radix Paeoniae Rubra 4 grams, Radix Glycyrrhizae Preparata 2 grams, Radix Curcumae 3 grams, Pericarpium Citri Reticulatae 3 grams, Radix Notoginseng 2 grams, Radix Puerariae 2 grams, Rhizoma Cimicifugae 2 grams, Colla Corii Asini 4 grams of colluding, extracting liquorice is fried with honey and is processed, then with Radix Glycyrrhizae and other 17 flavor Chinese medicine pulverize separately, sieve, add Rhizoma Chuanxiong 2.5 grams, mixing, add the rubbing of proper honey mixing, be molded into pill, every ball 9 grams get final product.
Case one: Liu * *, woman, 64 years old, because of nervous, dizzy, come to go to a doctor, continue, have lightening shock sometimes toward suffering from coronary heart disease, hypertension, hyperosteogeny, gastroenteritis, whole body joint pain for many years, numbness, the time angina pectoris arranged, blood pressure 190/100mmHg with old syndrome diagnosis and treatment, takes medicine of the present invention, every day 3 times, each 9 grams are advised and are stopped other drug, doing well,improving after 3 days, continue and obeyed 30 days, effect is remarkable, and activity is advised drug withdrawal freely, follow up a case by regular visits to, coronary heart disease, angina pectoris, hypertension is recurrence more not.
Case two: Xue * *, the man, 42 years old, the heart disease several years, electrocardiogram showed arrhythmia, and sense is nervous before examining increases the weight of, and heart uncomfortable in chest has bearing down, and stubborn insomnia is weak, the diet poor appetite.Examine and be qi depression to blood stasis, QI and blood deficiency, obey medicine of the present invention, every day 3 times, each 9 grams.After 3 days, nervous, uncomfortable in chest, tenesmus improves fully, can fall asleep safely.Advise 4 weeks of clothes of continuing, forbid drinking.Follow up a case by regular visits to, it is imitated significantly, not recurrence again.
Table 2:
Nomenclature of drug | Case load | Produce effects | Effectively | Invalid | Total effective rate % |
Storax pill for treating coronary heart disease | 20 | 6 | 5 | 9 | 55% |
Battalion's heart pellet | 202 | 73 | 106 | 23 | 88.6% |
Guanxinkang Granule | 304 | 111 | 135 | 58 | 80.9% |
The invention medicine | 129 | 41 | 85 | 3 | 97.7% |
Claims (3)
1, the cardiopathic medicine of a kind of treatment is characterized in that its prescription proportioning is substantially: Radix Salviae Miltiorrhizae 10, two 2-4 of colluding, Spica Prunellae 2-4, Radix Sophorae Flavescentis 5-8, Radix Codonopsis 4-7, LISHEN 2-4, Radix Ophiopogonis 1-3, Fructus Schisandrae Chinensis 1-2, Radix Astragali 2-5, Radix Angelicae Sinensis 1-2, Radix Paeoniae Rubra 2-4, Radix Glycyrrhizae Preparata 1-2, Radix Curcumae 1-3, Pericarpium Citri Reticulatae 1-3, Radix Notoginseng 1-2, Radix Puerariae 1-2, Rhizoma Cimicifugae 1-2, Colla Corii Asini 2-4.
2,, it is characterized in that said prescription proportioning can be substantially according to the cardiopathic medicine of the said treatment of claim 1: Radix Salviae Miltiorrhizae 10, two 2.5-4 of colluding, Spica Prunellae 2.5-4, Radix Sophorae Flavescentis 5.5-7, Radix Codonopsis 3.5-6, LISHEN 2.5-3.5, Radix Ophiopogonis 1.5-2.5, Fructus Schisandrae Chinensis 1.5, Radix Astragali 2.5-4.5, Radix Angelicae Sinensis 1.5, Radix Paeoniae Rubra 2.5-3.5, Radix Glycyrrhizae Preparata 1.5, Radix Curcumae 1.5-3, Pericarpium Citri Reticulatae 1.5-3, Radix Notoginseng 1.5, Radix Puerariae 1.5, Rhizoma Cimicifugae 1.5, Colla Corii Asini 2.5-3.5.
3, according to the cardiopathic medicine of treatment of claim 1 or 2 regulations, it is characterized in that can being added with Rhizoma Chuanxiong in said medicine, the ratio of Rhizoma Chuanxiong in medicine is 2.5-2.8.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN96115786A CN1060665C (en) | 1996-05-10 | 1996-05-10 | Medicine for heart disease |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN96115786A CN1060665C (en) | 1996-05-10 | 1996-05-10 | Medicine for heart disease |
Publications (2)
Publication Number | Publication Date |
---|---|
CN1147401A true CN1147401A (en) | 1997-04-16 |
CN1060665C CN1060665C (en) | 2001-01-17 |
Family
ID=5123004
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN96115786A Expired - Fee Related CN1060665C (en) | 1996-05-10 | 1996-05-10 | Medicine for heart disease |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN1060665C (en) |
Cited By (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1064542C (en) * | 1997-09-19 | 2001-04-18 | 王大志 | Traditional Chinese medicine for treatment of chronic rheumatic heart disease |
US7381429B2 (en) | 2000-06-29 | 2008-06-03 | Dr. Willmar Schwabe Gmbh & Co. | Extracts from sophora species, method for producing the same and their use |
CN101554412B (en) * | 2008-04-09 | 2011-01-19 | 北京绿源求证科技发展有限责任公司 | Traditional Chinese medicine for treating atrial fibrillation |
CN102526452A (en) * | 2012-01-19 | 2012-07-04 | 唐山市中医医院 | Traditional Chinese medicine decoction for treating sick sinus syndrome |
CN103989810A (en) * | 2010-05-27 | 2014-08-20 | 王伟 | A composite traditional Chinese medicine used for treating coronary heart disease cardiac insufficiency and a preparing method thereof |
CN104887861A (en) * | 2015-06-29 | 2015-09-09 | 张保菊 | Preparation for coronary heart disease and preparation method thereof |
CN104906277A (en) * | 2015-06-29 | 2015-09-16 | 张保菊 | Traditional Chinese medicine preparation for treating coronary heart disease |
CN104906516A (en) * | 2015-06-29 | 2015-09-16 | 张保菊 | Traditional Chinese medicinal composition for treating coronary heart disease and preparation method of traditional Chinese medicinal composition |
CN104906265A (en) * | 2015-06-29 | 2015-09-16 | 张保菊 | Traditional Chinese medicine composition for treating coronary heart disease |
CN105079701A (en) * | 2015-08-26 | 2015-11-25 | 林爱玲 | Traditional Chinese medicine for treating arrhythmia |
CN105079299A (en) * | 2015-04-16 | 2015-11-25 | 张希梅 | Medicine for treating infantile viral myocarditis |
CN105125996A (en) * | 2015-10-05 | 2015-12-09 | 南京多宝生物科技有限公司 | Pharmaceutical preparation for treating unstable angina pectoris of aged coronary heart disease |
-
1996
- 1996-05-10 CN CN96115786A patent/CN1060665C/en not_active Expired - Fee Related
Cited By (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1064542C (en) * | 1997-09-19 | 2001-04-18 | 王大志 | Traditional Chinese medicine for treatment of chronic rheumatic heart disease |
US7381429B2 (en) | 2000-06-29 | 2008-06-03 | Dr. Willmar Schwabe Gmbh & Co. | Extracts from sophora species, method for producing the same and their use |
CN101554412B (en) * | 2008-04-09 | 2011-01-19 | 北京绿源求证科技发展有限责任公司 | Traditional Chinese medicine for treating atrial fibrillation |
CN103989810A (en) * | 2010-05-27 | 2014-08-20 | 王伟 | A composite traditional Chinese medicine used for treating coronary heart disease cardiac insufficiency and a preparing method thereof |
CN103989810B (en) * | 2010-05-27 | 2016-05-11 | 王伟 | A kind of tcm components that heart function of coronary heart disease is incomplete and preparation method thereof that is used for the treatment of |
CN102526452A (en) * | 2012-01-19 | 2012-07-04 | 唐山市中医医院 | Traditional Chinese medicine decoction for treating sick sinus syndrome |
CN105079299A (en) * | 2015-04-16 | 2015-11-25 | 张希梅 | Medicine for treating infantile viral myocarditis |
CN105079299B (en) * | 2015-04-16 | 2016-05-11 | 杨池菊 | A kind of medicine for the treatment of infantile viral myocarditis |
CN104906277A (en) * | 2015-06-29 | 2015-09-16 | 张保菊 | Traditional Chinese medicine preparation for treating coronary heart disease |
CN104906265A (en) * | 2015-06-29 | 2015-09-16 | 张保菊 | Traditional Chinese medicine composition for treating coronary heart disease |
CN104906516A (en) * | 2015-06-29 | 2015-09-16 | 张保菊 | Traditional Chinese medicinal composition for treating coronary heart disease and preparation method of traditional Chinese medicinal composition |
CN104887861A (en) * | 2015-06-29 | 2015-09-09 | 张保菊 | Preparation for coronary heart disease and preparation method thereof |
CN105079701A (en) * | 2015-08-26 | 2015-11-25 | 林爱玲 | Traditional Chinese medicine for treating arrhythmia |
CN105125996A (en) * | 2015-10-05 | 2015-12-09 | 南京多宝生物科技有限公司 | Pharmaceutical preparation for treating unstable angina pectoris of aged coronary heart disease |
Also Published As
Publication number | Publication date |
---|---|
CN1060665C (en) | 2001-01-17 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN101129491B (en) | Medicated pillow for treating hypertension and method of preparing the same | |
CN100382839C (en) | Chinese-medicinal composition for treating coronary heart disease | |
CN1060665C (en) | Medicine for heart disease | |
CN101332246B (en) | Traditional Chinese medicine preparation for treating coronary heart disease and angina | |
CN1393257A (en) | Medicine for treating cardiovascular disease | |
CN1102987A (en) | Changyanling medicine for curing enteritis | |
CN101468148B (en) | Chinese medicinal composition for treating coronary heart disease and cerebral arteriosclerosis, and method for preparing the same | |
CN1199664C (en) | Chinese medicine for treating cardiovascular and cerebrovascular diseases and its preparing process | |
CN101791332B (en) | Compound gingko health product solid preparation | |
CN1041495C (en) | External application medicine for curing hepatic disease | |
Peigen et al. | Recent advances in clinical studies of Chinese medicinal herbs 1. Drugs affecting the cardiovascular system | |
CN110882347A (en) | A Chinese medicinal composition for treating cardiovascular diseases | |
CN1074292C (en) | Cancer treating medicine capsule | |
CN101574450B (en) | Drug for treating heart disease and preparation method thereof | |
CN111388623B (en) | Traditional Chinese medicine for treating coronary heart disease | |
CN1219540C (en) | Chinese medicine for treating leukoderma and the prepn process of the tablets | |
CN1248684C (en) | Chinese medicine powder for curing cardiovascular disease and preparing method thereof | |
CN111388564B (en) | Traditional Chinese medicine for treating bradyarrhythmia | |
CN101983712A (en) | Novel medicament for treating coronary heart disease | |
CN1242198A (en) | Traditional Chinese medicine capsule for treating coronary heart disease | |
CN106177422A (en) | A kind of Chinese medicine formula of warming YANG to expel cold | |
CN1490028A (en) | Chinese medicinal preparations for cardiac and encephalic blood vessel diseases and productions thereof | |
CN1063074C (en) | Chinese herbs injection for treating oncoma (cancer) and preparation method | |
CN1196936A (en) | Medicament for treating primary glomerular disease and its prepn. method | |
CN104667203A (en) | Medicine for treating coronary heart disease |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
C57 | Notification of unclear or unknown address | ||
DD01 | Delivery of document by public notice |
Addressee: Pan Xingguang Document name: Notification of Termination of Patent Right |
|
C19 | Lapse of patent right due to non-payment of the annual fee | ||
CF01 | Termination of patent right due to non-payment of annual fee |